Ann: Appendix 4C - quarterly, page-31

I agree it doesn't read super well, but it takes a bit to sort out others mess... Lets start from July 1 2017, the figures between here and December 31 2017 not good. 6 months of pain,  raising money, dilution, board changes, more bleeding of cash...but there was some good news, signing of contracts, training of sales staff(China), raising of funds etc.. The patient was nearly  dead, jump started the heart, and 6 months of painful recovery. Out of hospital now. I don't look at anything prior to July 1 2017.
Jan 1 2018 advised that sales being accrued, February 2018 product being deployed...Sales team training continuing, more customers, more sales.... soon company break even costs met (3-6 months??) then high profit from future growth in the worlds biggest market....
Further expansion internationally being worked on at same time....
This has finally become a real business, with a real product and real sales... As a shareholder I'm thankful its still alive and I understand a little more time is needed...